THE RABBIT SAPHENOUS-VEIN - A TISSUE-PREPARATION SPECIFICALLY ENRICHED IN NPY-Y1 RECEPTOR SUBTYPE

被引:18
作者
CADIEUX, A [1 ]
PHENG, LH [1 ]
STPIERRE, S [1 ]
FOURNIER, A [1 ]
BENCHEKROUN, MT [1 ]
机构
[1] UNIV QUEBEC,INRS SANTE,POINTE CLAIRE,PQ,CANADA
关键词
NEUROPEPTIDE-Y; RECEPTOR SUBTYPE; BLOOD VESSEL; STRUCTURE-ACTIVITY; BIOASSAY;
D O I
10.1016/0167-0115(93)90257-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neuropeptide Y (NPY), a co-transmitter in noradrenergic sympathetic nerves of the cardiovascular system, was tested on isolated segments of rabbit saphenous vein. NPY caused strong, long lastening and concentration dependent contraction resistant to adrenergic blockade. PYY, a NPY related peptide, shared this property. As pressor agents, both peptides were about 100-fold more potent than norepinephrine and at their highest concentrations caused a contraction of a similar magnitude as NE. Gradual shortening of N-terminal end of the NPY molecule caused major loss of potency and reduction of intrinsic activity; which suggests that the entire molecule is required to produce full biological activity in this vascular preparation. Addition of [Leu31,Pro34]pNPY, a NPY analog with specific agonist properties at Y1 receptors, mimicked the effect of NPY whereas NPY (13-36), a selective agonist at Y2 receptors, caused a 2 log unit shift to the right of the concentration response curve. These results suggest that the vasoconstrictor effect of NPY in rabbit saphenous vein results from a direct effect on smooth muscle cells and that the receptors involved are of the Y1 subtype.
引用
收藏
页码:557 / 564
页数:8
相关论文
共 39 条
[11]   NEUROPEPTIDE-Y CO-EXISTS AND CO-OPERATES WITH NORADRENALINE IN PERIVASCULAR NERVE-FIBERS [J].
EKBLAD, E ;
EDVINSSON, L ;
WAHLESTEDT, C ;
UDDMAN, R ;
HAKANSON, R ;
SUNDLER, F .
REGULATORY PEPTIDES, 1984, 8 (03) :225-235
[12]   DIFFERENTIAL CO-EXISTENCE OF NEUROPEPTIDE-Y (NPY)-LIKE IMMUNOREACTIVITY WITH CATECHOLAMINES IN THE CENTRAL NERVOUS-SYSTEM OF THE RAT [J].
EVERITT, BJ ;
HOKFELT, T ;
TERENIUS, L ;
TATEMOTO, K ;
MUTT, V ;
GOLDSTEIN, M .
NEUROSCIENCE, 1984, 11 (02) :443-&
[13]   STRUCTURAL STUDY OF THE N-TERMINAL SEGMENT OF NEUROPEPTIDE TYROSINE [J].
FOREST, M ;
MARTEL, JC ;
STPIERRE, S ;
QUIRION, R ;
FOURNIER, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (06) :1615-1619
[14]   [LEU31,PRO34]NEUROPEPTIDE-Y - A SPECIFIC Y-1 RECEPTOR AGONIST [J].
FUHLENDORFF, J ;
GETHER, U ;
AAKERLUND, L ;
LANGELANDJOHANSEN, N ;
THOGERSEN, H ;
MELBERG, SG ;
OLSEN, UB ;
THASTRUP, O ;
SCHWARTZ, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (01) :182-186
[15]  
FURCHGOTT RF, 1953, J PHARMACOL EXP THER, V108, P129
[16]   NEUROPEPTIDES CONTAINED IN PERIPHERAL CARDIOVASCULAR NERVES [J].
FURNESS, JB ;
COSTA, M ;
PAPKA, RE ;
DELLA, NG ;
MURPHY, R .
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1984, 6 (1-2) :91-106
[17]   NEUROPEPTIDE-Y POTENTIATES CONTRACTION AND INHIBITS RELAXATION OF RABBIT CORONARY-ARTERIES [J].
HAN, C ;
ABEL, PW .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 9 (06) :675-681
[18]  
HIEBLE JP, 1989, J PHARMACOL EXP THER, V250, P523
[19]  
KIMMEL JR, 1975, J BIOL CHEM, V250, P9369
[20]  
LI W, 1990, EUR J PHARM MOL PHAR, V207, P89